226 related articles for article (PubMed ID: 28626164)
21. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
23. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
24. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R
Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic value of soluble B7-H4 in malignant pleural effusion].
Xu CH; Yu LK
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):117-8. PubMed ID: 22490695
[TBL] [Abstract][Full Text] [Related]
26. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer.
Ishimoto O; Saijo Y; Narumi K; Kimura Y; Ebina M; Matsubara N; Asou N; Nakai Y; Nukiwa T
Oncology; 2002; 63(1):70-5. PubMed ID: 12187074
[TBL] [Abstract][Full Text] [Related]
27. [Early secretory antigenic target protein-6/culture filtrate protein-10 fusion protein-specific Th1 and Th2 response and its diagnostic value in tuberculous pleural effusion].
Ge QP; He ZY; Gao WW; DU FJ; Wei PJ; Jia HY; Ma Y; Zhang ZD
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):406-10. PubMed ID: 24103202
[TBL] [Abstract][Full Text] [Related]
28. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
Zhou J; Zhao Q; Yao H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
[TBL] [Abstract][Full Text] [Related]
29. [Interleukin-20 and interleukin-22 in pleural effusion].
Cao TZ; Du RH; Lian Z; Jin W; Qiu M
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Aug; 39(8):608-11. PubMed ID: 27523894
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of vascular endothelial growth factor in patients with primary lung cancer.
Kishiro I; Kato S; Fuse D; Yoshida T; Machida S; Kaneko N
Respirology; 2002 Jun; 7(2):93-8. PubMed ID: 11985729
[TBL] [Abstract][Full Text] [Related]
32. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.
Shu J; Sun G; Liu H; Liu J
Acta Oncol; 2007; 46(7):1004-11. PubMed ID: 17917830
[TBL] [Abstract][Full Text] [Related]
33. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
Liu G; Li C; Zhong X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
[TBL] [Abstract][Full Text] [Related]
34. Clinical implications of serum hypoxia inducible factor-1α and vascular endothelial growth factor in lung cancer.
Shen H; Feng G; Cui J; Du Q; Qin Y; Cai J; Shen L; Zhu Y
Tumori; 2015; 101(4):404-11. PubMed ID: 25983091
[TBL] [Abstract][Full Text] [Related]
35. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
[TBL] [Abstract][Full Text] [Related]
36. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
Li R; Gao Z; Dong K; Wang H; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion.
Hiraki A; Aoe K; Matsuo K; Murakami K; Murakami T; Onoda T; Sugi K; Takeyama H; Eda R
Int J Tuberc Lung Dis; 2003 Dec; 7(12):1172-7. PubMed ID: 14677892
[TBL] [Abstract][Full Text] [Related]
38. Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.
Shi J; Li P; Zhou L; Qi S; Wang B; Li D; Duan L; Chen WX; Xia J; Zou L; Yang S
Biomark Med; 2019 Feb; 13(2):123-133. PubMed ID: 30791695
[TBL] [Abstract][Full Text] [Related]
39. Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions.
Tomimoto H; Yano S; Muguruma H; Kakiuchi S; Sone S
J Med Invest; 2007 Feb; 54(1-2):146-53. PubMed ID: 17380026
[TBL] [Abstract][Full Text] [Related]
40. Clinical utility of pleural fluid YKL-40 as a marker of malignant pleural effusion.
Javath Hussain S; Selvaraj J; Mohanty Mohapatra M; Rajendiran S
Curr Probl Cancer; 2019 Aug; 43(4):354-362. PubMed ID: 30471784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
